0001415889-24-004183.txt : 20240216 0001415889-24-004183.hdr.sgml : 20240216 20240216173934 ACCESSION NUMBER: 0001415889-24-004183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Torley Helen CENTRAL INDEX KEY: 0001528185 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32335 FILM NUMBER: 24649791 MAIL ADDRESS: STREET 1: C/O ONYX PHARMACEUTICALS, INC. STREET 2: 249 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001159036 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880488686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 794-8889 MAIL ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC DATE OF NAME CHANGE: 20040312 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC DATE OF NAME CHANGE: 20010912 4 1 form4-02162024_100226.xml X0508 4 2024-02-15 0001159036 HALOZYME THERAPEUTICS, INC. HALO 0001528185 Torley Helen C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL SAN DIEGO CA 92130 true true false false PRESIDENT AND CEO 0 Common Stock 2024-02-15 4 M 0 13092 0 A 651096 D Common Stock 2024-02-15 4 F 0 7036 35.91 D 644060 D Common Stock 2024-02-15 4 A 0 32781 0 A 676841 D Common Stock 2024-02-15 4 F 0 17619 35.91 D 659222 D Restricted Stock Units 0 2024-02-15 4 M 0 13092 0 D Common Stock 13092 13092 D The reported disposition of 7,036 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. The reported disposition of 17,619 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. /s/ James R. Oehler, Attorney-in-Fact 2024-02-16